These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3938729)

  • 21. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Systematic inhibition of the luteinizing hormone with a gonadoliberin analog, triptorelin, during ovarian stimulation for fertilization in vitro. Choice of protocol].
    Fenichel P; Grimaldi M; Hieronimus S; Olivero JF; Donzeau A; Benoit B; Fiorentini M; Tran DK; Harter M; Gillet JY
    Presse Med; 1988 Apr; 17(15):719-22. PubMed ID: 2968548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of synthetic luteinizing hormone-releasing hormone on plasma luteinizing hormone and follicle-stimulating hormone in amenorrheic women.
    Rannevik G; Jeppsson S; Kullander S; Thorell J
    Fertil Steril; 1974 Jul; 25(7):547-55. PubMed ID: 4601915
    [No Abstract]   [Full Text] [Related]  

  • 25. Gonadotropin-releasing hormone agonist (leuprolide acetate) induced ovarian hyperstimulation syndrome in a woman undergoing intermittent hemodialysis.
    Hampton HL; Whitworth NS; Cowan BD
    Fertil Steril; 1991 Feb; 55(2):429-31. PubMed ID: 1899400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.
    Parmar H; Rustin G; Lightman SL; Phillips RH; Hanham IW; Schally AV
    Br Med J (Clin Res Ed); 1988 Apr; 296(6631):1229. PubMed ID: 2968130
    [No Abstract]   [Full Text] [Related]  

  • 27. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.
    Meldrum DR; Chang RJ; Lu J; Vale W; Rivier J; Judd HL
    J Clin Endocrinol Metab; 1982 May; 54(5):1081-3. PubMed ID: 6801075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of a gonadoliberin agonist with or without gonadoliberin pulses for ovulation induction in ovarian dystrophies].
    Colombo PL; Dumoulin S; Saint-Martin F; Caron P; Bennet A; Louvet JP
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(4):362-7. PubMed ID: 7650311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Endocrine effects of laser vaporization of the ovaries in women with polycystic ovary syndrome].
    Rossmanith WG; Keckstein J; Spatzier K; Lauritzen C
    Gynakol Rundsch; 1991; 31 Suppl 2():333-5. PubMed ID: 1790971
    [No Abstract]   [Full Text] [Related]  

  • 31. [The physiology of the follicle-stimulating hormone FSH: effect on ovarian granulosa cells].
    Netter A; Blacker C; Wahl P; Quereux C; Gabriel R; Scholler R
    Bull Acad Natl Med; 1987 Mar; 171(3):371-7. PubMed ID: 2959354
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome.
    Comite F; Shawker TH; Pescovitz OH; Loriaux DL; Cutler GB
    N Engl J Med; 1984 Oct; 311(16):1032-6. PubMed ID: 6434946
    [No Abstract]   [Full Text] [Related]  

  • 33. Simultaneous pulsatile release of prolactin and luteinizing hormone induced by luteinizing hormone-releasing factor agonist.
    Casper RF; Yen SS
    J Clin Endocrinol Metab; 1981 May; 52(5):934-6. PubMed ID: 7014588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two partial remissions induced by an LHRH analogue in two postmenopausal women with metastatic breast cancer.
    Schwartz L; Guiochet N; Keiling R
    Cancer; 1988 Dec; 62(12):2498-500. PubMed ID: 2973369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Observations on the course of advanced ovarian cancers following medicamentous reduction of hypophyseal gonadotropins].
    Jäger W; Wildt L; Lang N
    Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):611-7. PubMed ID: 2528495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of deslorelin acetate implants in horses: single implants in stallions and steroid-treated geldings and multiple implants in mares.
    Johnson CA; Thompson DL; Cartmill JA
    J Anim Sci; 2003 May; 81(5):1300-7. PubMed ID: 12772858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR; Aceto T; Weber C; Pang S
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration.
    Pavlou SN; Dahl KD; Wakefield G; Rivier J; Vale W; Hsueh AJ; Lindner J
    J Clin Endocrinol Metab; 1988 May; 66(5):1005-9. PubMed ID: 2834409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.